-
SURF Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Surface Oncology (SURF)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 66 |
Opened positions | 13 |
Closed positions | 21 |
Increased positions | 7 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 15.68 bn |
Total shares | 32.83 mm |
Total puts | 20.00 k |
Total calls | 51.20 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Armistice Capital | 4.89 mm | $4.25 bn |
Novartis Institutes for BioMedical Research | 3.95 mm | $36.48 mm |
Lilly Ventures Fund I | 3.45 mm | $31.86 mm |
Atlas Venture Associates IX | 2.95 mm | $2.56 bn |
Atlas Venture Fund IX | 2.95 mm | $0.00 |
Vanguard | 2.31 mm | $2.01 bn |
LLY Eli Lilly and | 1.59 mm | $7.62 mm |
Venrock Healthcare Capital Partners II | 1.44 mm | $13.33 mm |
ARK Investment Management | 1.41 mm | $1.23 bn |
DAFNA Capital Management | 1.10 mm | $956.56 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Sep 23 | Jessica Fees | Common Stock | Sale back to company | Dispose D | No | No | 0 | 101,915 | 0.00 | 0 |
8 Sep 23 | Jessica Fees | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 150,000 | 103.50 k | 0 |
8 Sep 23 | Chandra Adams | Common Stock | Sale back to company | Dispose D | No | No | 0 | 23,884 | 0.00 | 0 |
8 Sep 23 | Chandra Adams | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 50,000 | 34.50 k | 0 |
8 Sep 23 | Chandra Adams | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 50,000 | 34.50 k | 0 |
8 Sep 23 | Vito J. Palombella | Common Stock | Sale back to company | Dispose D | No | No | 0 | 87,212 | 0.00 | 0 |
8 Sep 23 | Vito J. Palombella | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 150,000 | 103.50 k | 0 |
8 Sep 23 | Goater Jeff | Common Stock | Sale back to company | Dispose D | No | No | 0 | 129,222 | 0.00 | 0 |
8 Sep 23 | Alison Oneill | Common Stock | Sale back to company | Dispose D | No | No | 0 | 56,686 | 0.00 | 0 |
8 Sep 23 | Alison Oneill | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 150,000 | 103.50 k | 0 |